Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Health care costs for patients with cancer at the end of life.
Chastek B, Harley C, Kallich J, Newcomer L, Paoli CJ, Teitelbaum AH. Chastek B, et al. J Oncol Pract. 2012 Nov;8(6):75s-80s. doi: 10.1200/JOP.2011.000469. Epub 2012 Jul 3. J Oncol Pract. 2012. PMID: 23598848 Free PMC article.
Comparison of COPD health care utilization and associated costs across patients treated with LAMA+LABA fixed-dose therapies.
Palli SR, Xie B, Chastek B, Elliott CA, Bengtson LGS. Palli SR, et al. Among authors: chastek b. J Manag Care Spec Pharm. 2021 Jul;27(7):810-824. doi: 10.18553/jmcp.2021.20514. Epub 2021 Mar 25. J Manag Care Spec Pharm. 2021. PMID: 33764161 Free PMC article.
OBJECTIVE: To compare chronic obstructive pulmonary disease (COPD)-related and all-cause health care resource utilization (HCRU) and costs between COPD patients initiating tiotropium (TIO) + olodaterol (OLO) versus (a) other LAMA + LABA FDCs and (b) umeclidinium (UMEC) + v …
OBJECTIVE: To compare chronic obstructive pulmonary disease (COPD)-related and all-cause health care resource utilization (HCRU) and costs b …
Economic impact of applying the AASLD-IDSA simplified treatment algorithm on the real-world management of hepatitis C.
Majethia S, Lee IH, Chastek B, Bunner S, Wolf J, Hsiao A, Mozaffari E. Majethia S, et al. Among authors: chastek b. J Manag Care Spec Pharm. 2022 Jan;28(1):48-57. doi: 10.18553/jmcp.2021.21246. Epub 2021 Oct 22. J Manag Care Spec Pharm. 2022. PMID: 34677088
Continuous enrollment 12 months before and 6 months after index date was required. Patients with claims for hepatitis B, HIV, decompensated liver, or prior DAAs were excluded. Patients were propensity score-matched (1:1) and grouped as "simplified" or "nonsimplified." ...M …
Continuous enrollment 12 months before and 6 months after index date was required. Patients with claims for hepatitis B, HIV, decompe …
40 results